AGENNIX AG i.L.

EANS-DD: AGENNIX AG
Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG

--------------------------------------------------------------------------------
  Notification concerning transactions by persons discharging managerial
  responsibilities pursuant to section 15a of the WpHG, transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is responsible
  for the content of this announcement.
-------------------------------------------------------------------------------- 
Details of the person subject to the disclosure requirement:
-------------------------------------------------------------------------------- 
Person, triggering the disclosure:
-----------------------------
Name:               dievini Hopp BioTech holding GmbH & Co. KG
                    (Legal person, company or institution) 
Reason for the disclosure requirement:
------------------------------
Reason:             Legal person, company or institution closely associated
Relationship:       To a person performing managerial responsibilities 
Person performing managerial responsibilities, triggering the disclosure
requirement: 
--------------------------------------------------------------------------------
Position:           Member of an administrative or supervisory body

Details of the transaction:
--------------------------------------------------------------------------------

Transaction:
------------
Description of financial instrument:  ordinary bearer shares with no par value
ISIN:                DE000A1A6XX4
Type of transaction: purchase
Date:                09.12.2010
Currency:            Euro
Price:               3.75000
No of items:         86206
Total amount traded: 323,272.50000
Place:               OTC
Explanation:         The sale by dievini Hopp BioTech holding GmbH & Co. KG is
                     attributed to the named members of the managing and
                     supervisoring bodies (Prof. von Bohlen und Halbach as a
                     member of the Management Board and Prof. Hettich as a
                     member of the Supervisory Board). 
Further inquiry note:
-----------------
Investor Relations & Corporate Communications
Tel.:     +49 (0) 89 8565 2693
E-Mail:ir@agennix.com 
Issuer subject to the publication requirement:
-------------------------------------------------------------------------------- 
end of announcement                               euro adhoc
-------------------------------------------------------------------------------- 

Further inquiry note:


Branche: Pharmaceuticals
ISIN: DE000A1A6XX4
WKN: A1A6XX
Index: CDAX, Prime All Share, Technology All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade

Original-Content von: AGENNIX AG i.L., übermittelt durch news aktuell

Weitere Meldungen: AGENNIX AG i.L.

Das könnte Sie auch interessieren: